Study to Evaluate the Ability of Sublingual MV130 to Induce the Expression of Trained Immunity in Peripheral Blood Cells

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
A mechanistic clinical trial with the aim to evaluate whether MV130 can induce the expression of a particular immune response (trained immunity) in peripheral blood cells. Therefore, the investigators are not evaluating efficacy in any disease or medical condition but rather assessing the immunological effect in immunogenicity of MV130 in healthy volunteers.
Epistemonikos ID: 34a56659ec1f2024f564fa2c2910d5e8b7369960
First added on: Oct 02, 2023